Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Psychotherapy
9 evidence topics · 8 sources
CANMAT guideline: psychotherapy after poor response to an initial antidepressant
“Based on efficacy and low potential for side effects, first-line psychological treatments should be considered early in the treatment course” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“There are few studies of psychotherapy for patients showing poor response to antidepressants.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Hence, CBT is recommended as a second-line adjunctive treatment, with medications, for DTD.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
NICE guideline: psychological therapy after no or limited response to medication
VA/DoD guideline: switching to or augmenting with psychotherapy
VA/DoD guideline: patient burden and access to psychotherapy
ACP guideline: switching to or augmenting with cognitive behavioral therapy
“ACP suggests one of the following options for patients in the acute phase of moderate to severe major depressive disorder who did not respond to initial treatment with an adequate dose of a second-generation antidepressant: • Switching to or augmenting with cognitive behavioral therapy (conditional recommendation; low-certainty evidence)” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Cognitive behavioral therapy added to usual care in primary care: response at 6 months
“This two parallel-group multicentre randomised controlled trial recruited 469 patients aged 18-75 years with treatment resistant depression (on antidepressants for ≥6 weeks, Beck depression inventory [BDI] score ≥14 and international classification of diseases [ICD]-10 criteria for depression) from 73 UK general practices.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The primary outcome was response, defined as at least 50% reduction in depressive symptoms (BDI score) at 6 months compared with baseline.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“95 participants (46%) in the intervention group met criteria for response at 6 months compared with 46 (22%) in the usual care group (odds ratio 3·26, 95% CI 2·10-5·06, p<0·001).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Because of the nature of the intervention it was not possible to mask participants, general practitioners, CBT therapists, or researchers to the treatment allocation.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Cognitive behavioral therapy added to usual care: long-term follow-up and cost-effectiveness
“Of these, 248 individuals completed a long-term follow-up questionnaire and provided data for the primary outcome (136 in the intervention group vs 112 in the usual care group). At follow-up (median 45·5 months [IQR 42·5-51·1]), the intervention group had a mean BDI-II score of 19·2 (SD 13·8) compared with a mean BDI-II score of 23·4 (SD 13·2) for the usual care group (repeated measures analysis over the 46 months: difference in means -4·7 [95% CI -6·4 to -3·0, p<0·001]).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The average annual cost of trial CBT per participant was £343 (SD 129). The incremental cost-effectiveness ratio was £5374 per QALY gain.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Psychological therapies for treatment-resistant depression: Cochrane review
“We included six trials (n = 698; most participants were women approximately 40 years of age). All studies evaluated psychotherapy plus usual care (with antidepressants) versus usual care (with antidepressants).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Moderate‐quality evidence for remission from six studies (RR 1.92, 95% CI 1.46 to 2.52; n = 635) and low‐quality evidence for response from four studies (RR 1.80, 95% CI 1.2 to 2.7; n = 556) indicate that psychotherapy was beneficial as an adjunct to usual care over the short term.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“High‐quality evidence shows no differential dropout (a measure of acceptability) between intervention and comparator groups over the short term (RR 0.85, 95% CI 0.58 to 1.24; six studies; n = 698).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“No evidence currently shows whether switching to a psychotherapy is more beneficial for this patient group than continuing an antidepressant medication regimen.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Psychotherapy for treatment-resistant depression: meta-analysis and meta-regression
“Seven different psychotherapies were studied in 21 trials that included a total of 25 comparisons. In three comparisons of psychotherapy v. treatment as usual (TAU) we found no evidence to conclude that there is a significant benefit of psychotherapy as compared with TAU. In 22 comparisons of add-on psychotherapy plus TAU v. TAU only, we found a moderate general effect size of 0.42 (95% CI 0.29-0.54) in favor of psychotherapy plus TAU.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Most frequent investigated treatments were cognitive behavior therapy, interpersonal psychotherapy, mindfulness-based cognitive therapy, and cognitive behavioral analysis system of psychotherapy.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote